Karalis et al. in this Special Issue demonstrate that treatment of triple negative breast cancer cells with salicylate (aspirin), a commonly used anti-inflammatory agent, affects the oncogenic HA network and cancer cell proliferation and migration due to decreased cyclin D expression and re-distribution of CD44 and actin cytoskeleton, respectively. The gene discussed is CD44; the disease is cancer.